UAE starts Sinopharm vaccine trials for children under 18
Lahore, 17th June: United Aarab Emirates (UAE) has started Sinopharm COVID-19 vaccine trials for children under 18 years of age.
According to reports from Emirates’ media office, some members of Abu Dhabi’s ruling family are participating in a trial administering China’s Sinopharm vaccine to children aged 3-17.
Abu Dhabi Media Office reported in a Twitter post on Wednesday that the trial will monitor the immune response of 900 children in order to vaccinate kids in the near future.
Theyab bin Mohamed bin Zayed accompanies his children, nieces and nephews, who join other families in Abu Dhabi as they participate in the Sinopharm immune bridge study for children aged 3 to 17.
— مكتب أبوظبي الإعلامي (@admediaoffice) June 16, 2021
Under the supervision of MoHAP and approved by @DoHSocial, the study is a significant next step in combating the pandemic. It is monitoring the immune response to the vaccine in 900 children, with full parental consent, in preparation to vaccinate children in the near future.
— مكتب أبوظبي الإعلامي (@admediaoffice) June 16, 2021
The Twitter post said that Sheikh Theyab bin Mohammed, a son of the United Arab Emirate’s de facto ruler and Abu Dhabi’s crown prince Sheikh Mohammed bin Zayed Al Nahyan, accompanied his children, nieces and nephews to participate in the immune bridge study.
It is to be noted that in May, UAE approved the Pfizer-BioNTech vaccine for emergency use in children aged 12-15. However, Dubai started immunizing that age group this month.
On Wednesday UAE registered 2,011 new coronavirus cases, taking its total toll to 603,961 cases with 1,738 deaths.
Follow Baaghi TV to read all the latest and trending news!
